Prostate Cancer Medicine Market 2027 By Drug Type, Distribution Channel and Geography | The Insight Partners

Prostate Cancer Medicine Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Drug Type (Chemotherapy, Biological Therapy, Hormone Therapy , Others); Distribution Channel (Hospitals Pharmacies, Drug Stores and Retail Pharmacies, Online Pharmacies) and Geography

Report Code: TIPRE00018115 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Prostate Cancer is a type of malignancy that occur in prostate gland and this cancer occur in men. The prostate gland is small walnut shaped gland that produces seminal fluid in men. Prostate cancer is the most common type of cancer in which one is fast growing which needs immediate treatment and another one is slow growing which need minimal or no treatment. The symptom of prostate cancer are pain while urinating, blood in urine and semen, bone pain, erectile dysfunction. Prostate cancer medicine are the group of therapies which are used in the treatment of prostate cancer.

MARKET DYNAMICS

The key market drivers for Prostate Cancer Medicine Market Includes, rising prevalence of prostate cancer along with increase in geriatric population across the globe. Additionally, increase in awareness in people about prostate cancer treatment along with rising R&D investments by pharmaceutical companies to develop novel therapies for management of prostate cancer is also expected to fuel market growth during forecast period. Whereas, possible side effects from treatment along with long duration of treatment is expected to restrain market growth during forecast period.

MARKET SCOPE

The "Prostate Cancer Medicine Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Prostate Cancer Medicine market with detailed market segmentation by drug type and distribution channel. The Prostate Cancer Medicine Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Prostate Cancer Medicine Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Prostate Cancer Medicine Market is segmented on the basis of drug type and distribution channel. On the basis of drug type the market is segmented as. Chemotherapy, biological therapy, hormone therapy and others. And on the basis of distribution channel the market is segmented as, hospital pharmacies, retail pharmacies, and online pharmacies.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Prostate Cancer Medicine Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Prostate Cancer Medicine Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Prostate Cancer Medicine Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Prostate Cancer Medicine Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Prostate Cancer Medicine Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Prostate Cancer Medicine Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Prostate Cancer Medicine market in the global market. Below mentioned is the list of few companies engaged in the Prostate Cancer Medicine Market.

The report also includes the profiles of key players in Prostate Cancer Medicine Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

  •   Astellas Pharma Inc.
  •   AstraZeneca plc.
  •   Bayer AG
  •   Bristol-Myers Squibb Company
  •   F. Hoffmann- La Roche AG
  •   Ferring Pharmaceuticals, Inc.
  •   GlaxoSmithKline Plc
  •   Ipsen pharma
  •   Johnson and Johnson
  •   Takeda Pharmaceutical Company Ltd

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Prostate Cancer Medicine Market - By Drug Type
1.3.2 Prostate Cancer Medicine Market - By Distribution Channel
1.3.3 Prostate Cancer Medicine Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. PROSTATE CANCER MEDICINE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS

5. PROSTATE CANCER MEDICINE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. PROSTATE CANCER MEDICINE MARKET - GLOBAL MARKET ANALYSIS
6.1. PROSTATE CANCER MEDICINE - GLOBAL MARKET OVERVIEW
6.2. PROSTATE CANCER MEDICINE - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. PROSTATE CANCER MEDICINE MARKET - REVENUE AND FORECASTS TO 2027 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. CHEMOTHERAPY
7.3.1. Overview
7.3.2. Chemotherapy Market Forecast and Analysis
7.4. BIOLOGICAL THERAPY
7.4.1. Overview
7.4.2. Biological Therapy Market Forecast and Analysis
7.5. HORMONE THERAPY
7.5.1. Overview
7.5.2. Hormone Therapy Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. PROSTATE CANCER MEDICINE MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS PHARMACIES
8.3.1. Overview
8.3.2. Hospitals Pharmacies Market Forecast and Analysis
8.4. DRUG STORES AND RETAIL PHARMACIES
8.4.1. Overview
8.4.2. Drug Stores and Retail Pharmacies Market Forecast and Analysis
8.5. ONLINE PHARMACIES
8.5.1. Overview
8.5.2. Online Pharmacies Market Forecast and Analysis

9. PROSTATE CANCER MEDICINE MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Prostate Cancer Medicine Market Overview
9.1.2 North America Prostate Cancer Medicine Market Forecasts and Analysis
9.1.3 North America Prostate Cancer Medicine Market Forecasts and Analysis - By Drug Type
9.1.4 North America Prostate Cancer Medicine Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Prostate Cancer Medicine Market Forecasts and Analysis - By Countries
9.1.5.1 United States Prostate Cancer Medicine Market
9.1.5.1.1 United States Prostate Cancer Medicine Market by Drug Type
9.1.5.1.2 United States Prostate Cancer Medicine Market by Distribution Channel
9.1.5.2 Canada Prostate Cancer Medicine Market
9.1.5.2.1 Canada Prostate Cancer Medicine Market by Drug Type
9.1.5.2.2 Canada Prostate Cancer Medicine Market by Distribution Channel
9.1.5.3 Mexico Prostate Cancer Medicine Market
9.1.5.3.1 Mexico Prostate Cancer Medicine Market by Drug Type
9.1.5.3.2 Mexico Prostate Cancer Medicine Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Prostate Cancer Medicine Market Overview
9.2.2 Europe Prostate Cancer Medicine Market Forecasts and Analysis
9.2.3 Europe Prostate Cancer Medicine Market Forecasts and Analysis - By Drug Type
9.2.4 Europe Prostate Cancer Medicine Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Prostate Cancer Medicine Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Prostate Cancer Medicine Market
9.2.5.1.1 Germany Prostate Cancer Medicine Market by Drug Type
9.2.5.1.2 Germany Prostate Cancer Medicine Market by Distribution Channel
9.2.5.2 France Prostate Cancer Medicine Market
9.2.5.2.1 France Prostate Cancer Medicine Market by Drug Type
9.2.5.2.2 France Prostate Cancer Medicine Market by Distribution Channel
9.2.5.3 Italy Prostate Cancer Medicine Market
9.2.5.3.1 Italy Prostate Cancer Medicine Market by Drug Type
9.2.5.3.2 Italy Prostate Cancer Medicine Market by Distribution Channel
9.2.5.4 Spain Prostate Cancer Medicine Market
9.2.5.4.1 Spain Prostate Cancer Medicine Market by Drug Type
9.2.5.4.2 Spain Prostate Cancer Medicine Market by Distribution Channel
9.2.5.5 United Kingdom Prostate Cancer Medicine Market
9.2.5.5.1 United Kingdom Prostate Cancer Medicine Market by Drug Type
9.2.5.5.2 United Kingdom Prostate Cancer Medicine Market by Distribution Channel
9.2.5.6 Rest of Europe Prostate Cancer Medicine Market
9.2.5.6.1 Rest of Europe Prostate Cancer Medicine Market by Drug Type
9.2.5.6.2 Rest of Europe Prostate Cancer Medicine Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Prostate Cancer Medicine Market Overview
9.3.2 Asia-Pacific Prostate Cancer Medicine Market Forecasts and Analysis
9.3.3 Asia-Pacific Prostate Cancer Medicine Market Forecasts and Analysis - By Drug Type
9.3.4 Asia-Pacific Prostate Cancer Medicine Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Prostate Cancer Medicine Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Prostate Cancer Medicine Market
9.3.5.1.1 Australia Prostate Cancer Medicine Market by Drug Type
9.3.5.1.2 Australia Prostate Cancer Medicine Market by Distribution Channel
9.3.5.2 China Prostate Cancer Medicine Market
9.3.5.2.1 China Prostate Cancer Medicine Market by Drug Type
9.3.5.2.2 China Prostate Cancer Medicine Market by Distribution Channel
9.3.5.3 India Prostate Cancer Medicine Market
9.3.5.3.1 India Prostate Cancer Medicine Market by Drug Type
9.3.5.3.2 India Prostate Cancer Medicine Market by Distribution Channel
9.3.5.4 Japan Prostate Cancer Medicine Market
9.3.5.4.1 Japan Prostate Cancer Medicine Market by Drug Type
9.3.5.4.2 Japan Prostate Cancer Medicine Market by Distribution Channel
9.3.5.5 South Korea Prostate Cancer Medicine Market
9.3.5.5.1 South Korea Prostate Cancer Medicine Market by Drug Type
9.3.5.5.2 South Korea Prostate Cancer Medicine Market by Distribution Channel
9.3.5.6 Rest of Asia-Pacific Prostate Cancer Medicine Market
9.3.5.6.1 Rest of Asia-Pacific Prostate Cancer Medicine Market by Drug Type
9.3.5.6.2 Rest of Asia-Pacific Prostate Cancer Medicine Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Prostate Cancer Medicine Market Overview
9.4.2 Middle East and Africa Prostate Cancer Medicine Market Forecasts and Analysis
9.4.3 Middle East and Africa Prostate Cancer Medicine Market Forecasts and Analysis - By Drug Type
9.4.4 Middle East and Africa Prostate Cancer Medicine Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Prostate Cancer Medicine Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Prostate Cancer Medicine Market
9.4.5.1.1 South Africa Prostate Cancer Medicine Market by Drug Type
9.4.5.1.2 South Africa Prostate Cancer Medicine Market by Distribution Channel
9.4.5.2 Saudi Arabia Prostate Cancer Medicine Market
9.4.5.2.1 Saudi Arabia Prostate Cancer Medicine Market by Drug Type
9.4.5.2.2 Saudi Arabia Prostate Cancer Medicine Market by Distribution Channel
9.4.5.3 U.A.E Prostate Cancer Medicine Market
9.4.5.3.1 U.A.E Prostate Cancer Medicine Market by Drug Type
9.4.5.3.2 U.A.E Prostate Cancer Medicine Market by Distribution Channel
9.4.5.4 Rest of Middle East and Africa Prostate Cancer Medicine Market
9.4.5.4.1 Rest of Middle East and Africa Prostate Cancer Medicine Market by Drug Type
9.4.5.4.2 Rest of Middle East and Africa Prostate Cancer Medicine Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Prostate Cancer Medicine Market Overview
9.5.2 South and Central America Prostate Cancer Medicine Market Forecasts and Analysis
9.5.3 South and Central America Prostate Cancer Medicine Market Forecasts and Analysis - By Drug Type
9.5.4 South and Central America Prostate Cancer Medicine Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Prostate Cancer Medicine Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Prostate Cancer Medicine Market
9.5.5.1.1 Brazil Prostate Cancer Medicine Market by Drug Type
9.5.5.1.2 Brazil Prostate Cancer Medicine Market by Distribution Channel
9.5.5.2 Argentina Prostate Cancer Medicine Market
9.5.5.2.1 Argentina Prostate Cancer Medicine Market by Drug Type
9.5.5.2.2 Argentina Prostate Cancer Medicine Market by Distribution Channel
9.5.5.3 Rest of South and Central America Prostate Cancer Medicine Market
9.5.5.3.1 Rest of South and Central America Prostate Cancer Medicine Market by Drug Type
9.5.5.3.2 Rest of South and Central America Prostate Cancer Medicine Market by Distribution Channel

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. PROSTATE CANCER MEDICINE MARKET, KEY COMPANY PROFILES
11.1. ASTELLAS PHARMA INC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ASTRAZENECA PLC
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. BAYER AG
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. BRISTOL-MYERS SQUIBB COMPANY
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. F. HOFFMANN-LA ROCHE AG
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. FERRING PHARMACEUTICALS INC.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. GLAXOSMITHKLINE PLC
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. IPSEN PHARMA
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. JOHNSON AND JOHNSON
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. TAKEDA PHARMACEUTICAL COMPANY LTD
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Astellas Pharma Inc.
2. AstraZeneca plc
3. Bayer AG
4. Bristol-Myers Squibb Company
5. F. Hoffmann-La Roche AG
6. Ferring Pharmaceuticals Inc.
7. GlaxoSmithKline Plc
8. Ipsen Pharma
9. Johnson and Johnson
10. Takeda Pharmaceutical Company Ltd
TIPRE00018115
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking